Navigating the enhancement landscape. Ethical issues in research on cognitive enhancers for healthy individuals. (Q36594188)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23318628%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

title

Navigating the enhancement landscape. Ethical issues in research on cognitive enhancers for healthy individuals (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23318628%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23318628%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Wayne Hall

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23318628%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Maartje H.N. Schermer

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23318628%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

8

Eric Racine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23318628%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

author name string

Bruce Maxwell

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23318628%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Simon M Outram

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23318628%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Peter B Reiner

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23318628%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Dimitris Repantis

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23318628%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

publication date

15 January 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23318628%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23318628%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23318628%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23318628%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

page(s)

123-128

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23318628%20AND%20SRC:MED&resulttype=core&format=json

Smart drugs "as common as coffee": media hype about neuroenhancement

22 February 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566849

Are prescription stimulants "smart pills"? The epidemiology and cognitive neuroscience of prescription stimulant use by normal healthy individuals

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566849

The ethics of elective psychopharmacology

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566849

The likelihood of cognitive enhancement

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566849

Physician attitudes towards pharmacological cognitive enhancement: safety concerns are paramount

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566849

Cognitive enhancement by drugs in health and disease

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566849

Nonmedical prescription stimulant use among college students: why we need to do something and what we need to do.

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566849

Neuroenhancement: wisdom of the masses or "false phronesis"?

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566849

Modafinil and methylphenidate for neuroenhancement in healthy individuals: A systematic review

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566849

Acetylcholinesterase inhibitors and memantine for neuroenhancement in healthy individuals: a systematic review

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566849

Responding to requests from adult patients for neuroenhancements: guidance of the Ethics, Law and Humanities Committee

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566849

Disagreements with implications: diverging discourses on the ethics of non-medical use of methylphenidate for performance enhancement

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566849

Cognitive enhancement: methods, ethics, regulatory challenges

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566849

Towards responsible use of cognitive-enhancing drugs by the healthy

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566849

The mental wealth of nations

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566849

Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566849

Botox for the brain: enhancement of cognition, mood and pro-social behavior and blunting of unwanted memories

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566849

Justice, fairness, and enhancement

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566849

Converging cognitive enhancements

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566849

Neurocognitive enhancement: what can we do and what should we do?

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566849

Selling sickness: the pharmaceutical industry and disease mongering

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566849

The use of methylphenidate among students: the future of enhancement?

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566849

Feeling 'better than well'.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566849

Ethical and legal issues in enhancement research on human subjects.

30 September 2017

1 reference

https://api.crossref.org/works/10.1038%2FEMBOR.2012.225

Expectations regarding cognitive enhancement create substantial challenges.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEMBOR.2012.225

Distinguishing between restoration and enhancement in neuropharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEMBOR.2012.225

Illicit methylphenidate use in an undergraduate student sample: prevalence and risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEMBOR.2012.225

Prevalence and motives for illicit use of prescription stimulants in an undergraduate student sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEMBOR.2012.225

Overcorrecting the neuroenhancement discussion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEMBOR.2012.225

Enhancing concentration, mood and memory in healthy individuals: an empirical study of attitudes among general practitioners and the general population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEMBOR.2012.225

Better evidence for safety and efficacy is needed before neurologists prescribe drugs for neuroenhancement to healthy people

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEMBOR.2012.225

Responding to requests from adult patients for neuroenhancements: guidance of the ethics, law and humanities committee.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEMBOR.2012.225

Cognitive neuroenhancement: false assumptions in the ethical debate.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566849

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566849

Weak evidence for large claims contribute to the phantom debate

20 September 2018

1 reference

https://api.crossref.org/works/10.1038%2FEMBOR.2012.225

“Doctor, Would You Prescribe a Pill to Help Me … ?” A National Survey of Physicians on Using Medicine for Human Enhancement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEMBOR.2012.225

Poll results: look who's doping

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEMBOR.2012.225

Ethical issues in the translation of social neuroscience: a policy analysis of current guidelines for public dialogue in human research

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566849

4 December 2018

Identifiers

DOI

10.1038/EMBOR.2012.225

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23318628%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23318628%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

PubMed publication ID

23318628

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23318628%20AND%20SRC:MED&resulttype=core&format=json